| Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology |
52 |
| Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines A Joint Recommendation of the Association for Molecular Pathology and the College of American Pathologists |
46 |
| Analytical Validation of a Hybrid Capture-Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA |
30 |
| Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy |
30 |
| Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR-Based Targeted Next-Generation Sequencing |
26 |
| Multi-Gene Panel Testing of 179 Individuals for Hereditary Cancer Risk Identifies Pathogenic Variant Carriers Missed by Current Genetic Testing Guidelines |
24 |
| Recommendations for Clinical CYP2C19 Genotyping Allele Selection A Report of the Association for Molecular Pathology |
21 |
| Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients |
20 |
| A Novel Next-Generation Sequencing Approach to Detecting Microsatellite Instability and Pan-Tumor Characterization of 1000 Microsatellite Instability-High Cases in 000 Patient Samples |
19 |
| A Novel and Reliable Method to Detect Microsatellite Instability in Colorectal Cancer by Next-Generation Sequencing |
15 |
| Automated Clinical Exome Reanalysis Reveals Novel Diagnoses |
14 |
| Analytical Validation of Variants to Aid in Genotype-Guided Therapy for Oncology |
14 |
| Leveraging Human Microbiome Features to Diagnose and Stratify Children with Irritable Bowel Syndrome |
13 |
| Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell Neoplasms |
12 |
| Development of Novel Mutation-Specific Droplet Digital PCR Assays Detecting TERT Promoter Mutations in Tumor and Plasma Samples |
11 |
| Clinical Significance of DNA Variants in Chronic Myeloid Neoplasms A Report of the Association for Molecular Pathology |
11 |
| Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma Management |
11 |
| Development and Evaluation of a Pan-Sarcoma Fusion Gene Detection Assay Using the NanoString nCounter Platform |
11 |
| Detection of EGFR Variants in Plasma A Multilaboratory Comparison of a Real-Time PCR EGFR Mutation Test in Europe |
10 |
| Clinical Evaluation of Massively Parallel RNA Sequencing for Detecting Recurrent Gene Fusions in Hematologic Malignancies |
9 |
| Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid Tumors |
9 |
| Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer |
8 |
| Noninvasive Molecular Monitoring in Multiple Myeloma Patients Using Cell-Free Tumor DNA A Pilot Study |
8 |
| Droplet Digital PCR for Mutation Detection in Formalin-Fixed, Paraffin-Embedded Melanoma Tissues A Comparison with Sanger Sequencing and Pyrosequencing |
8 |
| Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia |
8 |
| A Reliable Targeted Next-Generation Sequencing Strategy for Diagnosis of Myopathies and Muscular Dystrophies, Especially for the Giant Titin and Nebulin Genes |
8 |
| Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Forman-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer |
7 |
| Characterization of Reference Materials for Genetic Testing of CYP2D6 Alleles A GeT-RM Collaborative Project |
7 |
| Comparison of in Situ and Extraction-Based Methods for the Detection of ROS1 Rearrangements in Solid Tumors |
7 |
| Prospective Evaluation of the Vela Diagnostics Next-Generation Sequencing Platform for HIV-1 Genotypic Resistance Testing |
7 |
| Optimized Digital Droplet PCR for BCR-ABL |
7 |
| A Highly Sensitive and Robust Method for Hepatitis B Virus Covalently Closed Circular DNA Detection in Single Cells and Serum |
7 |
| Accurate Typing of Human Leukocyte Antigen Class I Genes by Oxford Nanopore Sequencing |
7 |
| Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing |
7 |
| Mutation Burden and I Index for Detection of Microsatellite Instability in Colorectal Cancer by Targeted Next-Generation Sequencing |
6 |
| Assessing the Accuracy of Variant Detection in Cost-Effective Gene Panel Testing by Next-Generation Sequencing |
6 |
| Validation and Implementation of BRCA1/2 Variant Screening in Ovarian Tumor Tissue |
6 |
| Electric Field-Induced Release and Measurement Liquid Biopsy for Noninvasive Early Lung Cancer Assessment |
6 |
| Comprehensive Genomic Profiling of Malignant Effusions in Patients with Metastatic Lung Adenocarcinoma |
6 |
| External Quality Assessment Identifies Training Needs to Determine the Neoplastic Cell Content for Biomarker Testing |
6 |
| Multilaboratory Assessment of a New Reference Material for Quality Assurance of Cell-Free Tumor DNA Measurements |
6 |
| A Rigorous Interlaboratory Examination of the Need to Confirm Next-Generation Sequencing-Detected Variants with an Orthogonal Method in Clinical Genetic Testing |
6 |
| Genomic Analysis of Circulating Tumor DNA Using a Melanoma-Specific UltraSEEK Oncogene Panel |
6 |
| A Nanopore Sequencing-Based Assay for Rapid Detection of Gene Fusions |
6 |
| Analytical Comparison of Methods for Extraction of Short Cell-Free DNA from Urine |
6 |
| t(3;8)(q26.2;q24) Often Leads to MECOM/MYC Rearrangement and Is Commonly Associated with Therapy-Related Myeloid Neoplasms and/or Disease Progression |
5 |
| Evaluation for Genetic Disorders in the Absence of a Clinical Indication for Testing Elective Genomic Testing |
5 |
| Screening for Regulatory Variants in 460 kb Encompassing the CFTR Locus in Cystic Fibrosis Patients |
5 |
| Considerations for Genomic Data Privacy and Security when Working in the Cloud |
5 |
| Somatic Tumor Variant Filtration Strategies to Optimize Tumor-Only Molecular Profiling Using Targeted Next-Generation Sequencing Panels |
5 |
